Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | REGISTRATION STATEMENT | ea0229836-s1_pmgchold.htm iXBRL | S-1 | 3247761 |
2 | ARTICLES OF INCORPORATION OF THE REGISTRANT | ea022983601ex3-1_pmgchold.htm | EX-3.1 | 1311 |
3 | BYLAWS OF REGISTRANT | ea022983601ex3-2_pmgchold.htm | EX-3.2 | 117408 |
4 | CERTIFICATE OF DESIGNATIONS, RIGHTS, AND PREFERENCES OF SERIES B PREFERRED STOCK | ea022983601ex3-3_pmgchold.htm | EX-3.3 | 6418 |
5 | 2020 EQUITY INCENTIVE PLAN, AS AMENDED, AND FORMS OF AWARD AGREEMENTS THEREUNDER | ea022983601ex10-1_pmgchold.htm | EX-10.1 | 175918 |
6 | FORM OF AMENDED AND RESTATED CONSULTING AGREEMENT BETWEEN THE REGISTRANT AND NOR | ea022983601ex10-2_pmgchold.htm | EX-10.2 | 37018 |
7 | FORM OF ADVISORY AGREEMENT BETWEEN THE REGISTRANT AND BRAEDEN LICHTI | ea022983601ex10-3_pmgchold.htm | EX-10.3 | 32590 |
8 | AUTHORIZED DISTRIBUTOR AGREEMENT, DATED AUGUST 30, 2022, BETWEEN THE REGISTRANT | ea022983601ex10-4_pmgchold.htm | EX-10.4 | 123804 |
9 | AUTHORIZED DISTRIBUTOR AND TRADEMARK LICENSE AGREEMENT, DATED JANUARY 17, 2022, | ea022983601ex10-5_pmgchold.htm | EX-10.5 | 120767 |
10 | COLLABORATION AGREEMENT, DATED NOVEMBER 28, 2023, BY AND BETWEEN THE REGISTRANT | ea022983601ex10-6_pmgchold.htm | EX-10.6 | 195659 |
11 | LICENSE AGREEMENT, DATED JANUARY 16, 2024, BY AND BETWEEN THE COMPANY AND INMUNE | ea022983601ex10-7_pmgchold.htm | EX-10.7 | 66795 |
12 | EMPLOYMENT AGREEMENT OF JORDAN R. PLEWS, DATED SEPTEMBER 26, 2021 | ea022983601ex10-8_pmgchold.htm | EX-10.8 | 39196 |
13 | EMPLOYMENT AGREEMENT OF BRENDA BUECHLER, DATED JUNE 24, 2022 | ea022983601ex10-9_pmgchold.htm | EX-10.9 | 42056 |
14 | EMPLOYMENT AGREEMENT OF CHRIS KRANEISS, DATED AUGUST 6, 2022 | ea022983601ex10-10_pmgchold.htm | EX-10.10 | 37429 |
15 | LICENSE AGREEMENT, DATED APRIL 30, 2024, BY AND BETWEEN THE COMPANY AND MOA LIFE | ea022983601ex10-11_pmgchold.htm | EX-10.11 | 197064 |
16 | CONSULTING AGREEMENT WITH SANTORIO BIOMEDICAL, LLC | ea022983601ex10-12_pmgchold.htm | EX-10.12 | 53639 |
17 | AMENDED AND RESTATED CONSULTING AGREEMENT BY AND BETWEEN THE COMPANY AND GB CAPI | ea022983601ex10-13_pmgchold.htm | EX-10.13 | 33716 |
18 | AMENDED AND RESTATED CONSULTING AGREEMENT BY AND BETWEEN THE COMPANY AND NORTHST | ea022983601ex10-14_pmgchold.htm | EX-10.14 | 30470 |
19 | CHAIRMAN APPOINTMENT LETTER TO MR. BRAEDEN LICHTI | ea022983601ex10-15_pmgchold.htm | EX-10.15 | 38865 |
20 | TERMINATION AGREEMENT BY AND BETWEEN THE COMPANY AND MR. LICHTI | ea022983601ex10-16_pmgchold.htm | EX-10.16 | 30510 |
21 | FIRST AMENDMENT TO LICENSE AGREEMENT DATED AS OF JULY 9, 2024, BY AND BETWEEN TH | ea022983601ex10-17_pmgchold.htm | EX-10.17 | 10107 |
22 | FORM OF SECURITIES PURCHASE AGREEMENT DATED SEPTEMBER 22, 2024 | ea022983601ex10-18_pmgchold.htm | EX-10.18 | 289921 |
23 | SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPLOYEE CHIEF EXECUTIV | ea022983601ex10-19_pmgchold.htm | EX-10.19 | 87807 |
24 | SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EXECUTIVE CHAIRMAN BY A | ea022983601ex10-20_pmgchold.htm | EX-10.20 | 95702 |
25 | AMENDMENT TO THE SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPLOY | ea022983601ex10-21_pmgchold.htm | EX-10.21 | 9574 |
26 | AMENDMENT TO THE SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EXECUT | ea022983601ex10-22_pmgchold.htm | EX-10.22 | 10361 |
27 | FORM OF WARRANT INDUCEMENT AGREEMENT | ea022983601ex10-23_pmgchold.htm | EX-10.23 | 55879 |
28 | FORM OF WARRANT | ea022983601ex10-24_pmgchold.htm | EX-10.24 | 150154 |
29 | LETTER FROM TPS THAYER, LLC | ea022983601ex16-1_pmgchold.htm | EX-16.1 | 2766 |
30 | LIST OF SUBSIDIARIES | ea022983601ex21-1_pmgchold.htm | EX-21.1 | 2250 |
31 | CONSENT OF TPS THAYER | ea022983601ex23-2_pmgchold.htm | EX-23.2 | 2628 |
32 | UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF INCOME OF THE COMPANY FOR THE FIS | ea022983601ex99-1_pmgchold.htm | EX-99.1 | 137337 |
33 | FILING FEE TABLE | ea022983601ex-fee_pmgchold.htm | EX-FILING FEES | 36591 |
34 | GRAPHIC | ex3-1_001.jpg | GRAPHIC | 383177 |
35 | GRAPHIC | ex3-1_002.jpg | GRAPHIC | 80612 |
36 | GRAPHIC | ex3-3_001.jpg | GRAPHIC | 1057502 |
37 | GRAPHIC | ex3-3_002.jpg | GRAPHIC | 1014703 |
38 | GRAPHIC | ex3-3_003.jpg | GRAPHIC | 1313391 |
39 | GRAPHIC | ex3-3_004.jpg | GRAPHIC | 1164808 |
40 | GRAPHIC | ex3-3_005.jpg | GRAPHIC | 1144845 |
41 | GRAPHIC | ex3-3_006.jpg | GRAPHIC | 1121200 |
42 | GRAPHIC | ex3-3_007.jpg | GRAPHIC | 706040 |
43 | GRAPHIC | ex3-3_008.jpg | GRAPHIC | 174028 |
44 | GRAPHIC | image_001.jpg | GRAPHIC | 16433 |
45 | GRAPHIC | ex10-15_001.jpg | GRAPHIC | 3166 |
Complete submission text file | 0001213900-25-012352.txt | 27340323 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
46 | XBRL SCHEMA FILE | pmgchi-20240930.xsd | EX-101.SCH | 95964 |
47 | XBRL CALCULATION FILE | pmgchi-20240930_cal.xml | EX-101.CAL | 57605 |
48 | XBRL DEFINITION FILE | pmgchi-20240930_def.xml | EX-101.DEF | 542477 |
49 | XBRL LABEL FILE | pmgchi-20240930_lab.xml | EX-101.LAB | 775222 |
50 | XBRL PRESENTATION FILE | pmgchi-20240930_pre.xml | EX-101.PRE | 572258 |
164 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0229836-s1_pmgchold_htm.xml | XML | 1958285 |
EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284851 | Film No.: 25611829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)